1. M.J. Gattuso, B. McCulloch, D.W. House, W.M. Baumann and K. Gottschall, Pharm. Tech. Eur., 8 (1996) 20.
2. I. Wainer, Pharm. News, 2 (1995) 19.
3. FDA's Policy statement for the development of new stereoisomeric drugs, Fed. Reg., 57 (102) (1992).
4. A. Richards, Scrip Mag., 5 (1995) 20.
5. W.E. Heydorn, Pharm. News, 2 (1995) 19.